250 related articles for article (PubMed ID: 30079604)
1. Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition.
Gurin D; Slavik M; Hermanova M; Shatokhina T; Sana J; Kazda T; Selingerova I; Ahmad P; Smilek P; Horakova Z; Hendrych M; Slampa P; Slaby O
J Oral Pathol Med; 2018 Oct; 47(9):864-872. PubMed ID: 30079604
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
[TBL] [Abstract][Full Text] [Related]
3. Impact of Expression of CD44, a Cancer Stem Cell Marker, on the Treatment Outcomes of Intensity Modulated Radiation Therapy in Patients With Oropharyngeal Squamous Cell Carcinoma.
Motegi A; Fujii S; Zenda S; Arahira S; Tahara M; Hayashi R; Akimoto T
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):461-8. PubMed ID: 26867875
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
Cohen ER; Reis IM; Gomez C; Pereira L; Freiser ME; Hoosien G; Franzmann EJ
Otolaryngol Head Neck Surg; 2017 Aug; 157(2):239-251. PubMed ID: 28397583
[TBL] [Abstract][Full Text] [Related]
5. Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual.
Beltz A; Gösswein D; Zimmer S; Limburg I; Wünsch D; Gribko A; Deichelbohrer M; Hagemann J; Stauber RH; Künzel J
Eur J Surg Oncol; 2019 Jun; 45(6):1046-1053. PubMed ID: 30857877
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
7. Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base.
Zhan KY; Eskander A; Kang SY; Old MO; Ozer E; Agrawal AA; Carrau RL; Rocco JW; Teknos TN
Oral Oncol; 2017 Oct; 73():152-159. PubMed ID: 28939068
[TBL] [Abstract][Full Text] [Related]
8. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
9. Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection.
Yamashita Y; Ikegami T; Hirakawa H; Uehara T; Deng Z; Agena S; Uezato J; Kondo S; Kiyuna A; Maeda H; Suzuki M; Ganaha A
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):827-836. PubMed ID: 30594962
[TBL] [Abstract][Full Text] [Related]
10. The 8th edition AJCC/UICC TNM staging for p16-positive oropharyngeal carcinoma: is there space for improvement?
Sharma SJ; Wagner S; Reder HSF; Kroll T; Wuerdemann N; Klussmann JP; Wittekindt C
Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):3087-3091. PubMed ID: 30327906
[TBL] [Abstract][Full Text] [Related]
11. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
[TBL] [Abstract][Full Text] [Related]
13. Utilizing the AJCC 8
Kim SI; Lee JW; Eun YG; Lee YC
Anticancer Res; 2024 Apr; 44(4):1703-1710. PubMed ID: 38538003
[TBL] [Abstract][Full Text] [Related]
14. Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort.
Geltzeiler M; Bertolet M; Albergotti W; Gleysteen J; Olson B; Persky M; Gross N; Li R; Andersen P; Kim S; Ferris RL; Duvvuri U; Clayburgh D
Oral Oncol; 2018 Sep; 84():82-87. PubMed ID: 30115481
[TBL] [Abstract][Full Text] [Related]
15. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
16. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF
Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
[TBL] [Abstract][Full Text] [Related]
19. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value and cost benefit of HPV testing for oropharyngeal cancer patients.
Lu XJD; Liu KYP; Prisman E; Wu J; Zhu YS; Poh C
Oral Dis; 2023 Mar; 29(2):483-490. PubMed ID: 34129700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
